HELPING YOU BUILD A BETTER TOMORROW
Tech Investing &
Growth Partnerships
Mission
As an owner-managed investment company, we invest in exceptional teams and future-oriented technologies – with capital, operational experience and over 30 years of entrepreneurial expertise.
Outstanding teams, innovative technologies and a strong growth orientation form the basis of our investment decision.
Investment
+30 successful investments
35 years of experience as
Entrepreneurs and investors
IT Managed Services
AI, SaaS
Bioscience
Venture & Growth Capital
Buy-outs
Portfolio
News
cosmico becomes part of the VALLEY IT GROUP
January 2024 - The VALLEY IT GROUP continues its strategic growth trajectory and strengthens its position in the managed services market: With the acquisition of cosmico GmbH, the group is strategically expanding its expertise, regional presence, and scalability in the DACH region (Germany, Austria, and Switzerland). This acquisition further strengthens the group's position, particularly in the SME sector. Based in Ehingen and Bad Saulgau (Baden-Württemberg), cosmico is an IT service provider specializing in managed services for medium-sized businesses and public sector institutions.
7CAP participates in Differential Bio
December 2024 - Differential Bio is a Munich-based biotech startup. The team is developing a virtual screening platform that utilizes scale-down experiments and AI-driven models to optimize growth conditions and bioprocesses for microbial growth and production. This dramatically increases R&D efficiency and improves fermentation outcomes such as yield, cost, and product quality.
Integer GmbH becomes part of the VALLEY IT GROUP
August 2024 - The VALLEY IT GROUP, a full-service IT provider for medium-sized businesses in German-speaking countries, has grown to seven members thanks to the acquisition of integer. Through this managed service provider based in Schrobenhausen, Bavaria, the VALLEY IT GROUP strengthens its presence in southern Germany and further expands its overall offering for customers in the DACH region (Germany, Austria, and Switzerland).
7CAP invests in PL BioScience
February 2024 - PL BioScience was founded in 2015 as a spin-off from RWTH Aachen University. PL BioScience holds a patent for a technology for the scale-up production of platelet-derived cell culture preparations and offers standardized human platelet lysates that ensure reproducible results.
About Us
We see ourselves as co-entrepreneurs
As entrepreneurs and investors, we have built several companies ourselves over the past 30 years and supported numerous others. With 7CAP, we invest in promising teams – and stand by their side as partners.
Our strength lies in
operational experience from own founding history
personal and strategic support of the portfolio companies
a well-established network in tech, SMEs and impact investing
Social responsibility
The economic success of our companies is also the foundation for our social commitment, which is particularly important to us. We support projects that ensure aid reaches those who urgently need it.
In particular, we do this through Bärenherz, an independent association that supports pre-defined projects in line with the association's philosophy through the personal and voluntary commitment of its members as well as income from charity events and donations.